☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
merck kgaa
PharmaShots Weekly Snapshots (May 20 – May 24, 2024)
May 24, 2024
Merck KGaA Reports the Acquisition of Mirus Bio, Strengthening Upstream Portfolio
May 23, 2024
Merck KGaA and Inspirna Collaborate for the Development and Commercialization of Ompenaclid (RGX-202) for the Treatment of Colorec...
January 5, 2024
Merck KGaA Reports Results for Evobrutinib in P-III Trial for the Treatment of Relapsing Multiple Sclerosis (RMS)
December 6, 2023
Merck KGaA and Hengrui Pharma Entered into a Licensing Agreement to Develop and Commercialize HRS-1167 and SHR-A1904 to Treat Canc...
October 31, 2023
Merck KGaA Reports P-III Trial (JAVELIN Bladder 100) Results of Bavencio (avelumab) in 1L Maintenance Treatment for Advanced Uroth...
February 14, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.